Global Parkinsons disease Drug Market Professional Survey Report 2019

Global Parkinsons disease Drug Market Professional Survey Report 2019

Table of Contents
Executive Summary
1 Industry Overview of Parkinsons disease Drug
1.1 Definition of Parkinsons disease Drug
1.2 Parkinsons disease Drug Segment by Type
1.2.1 Global Parkinsons disease Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Parkinsons disease Drug Segment by Applications
1.3.1 Global Parkinsons disease Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Online
1.3.4 Retail Pharmacies
1.4 Global Parkinsons disease Drug Overall Market
1.4.1 Global Parkinsons disease Drug Revenue (2014-2025)
1.4.2 Global Parkinsons disease Drug Production (2014-2025)
1.4.3 North America Parkinsons disease Drug Status and Prospect (2014-2025)
1.4.4 Europe Parkinsons disease Drug Status and Prospect (2014-2025)
1.4.5 China Parkinsons disease Drug Status and Prospect (2014-2025)
1.4.6 Japan Parkinsons disease Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Parkinsons disease Drug Status and Prospect (2014-2025)
1.4.8 India Parkinsons disease Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Parkinsons disease Drug
2.3 Manufacturing Process Analysis of Parkinsons disease Drug
2.4 Industry Chain Structure of Parkinsons disease Drug
3 Development and Manufacturing Plants Analysis of Parkinsons disease Drug
3.1 Capacity and Commercial Production Date
3.2 Global Parkinsons disease Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Parkinsons disease Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Parkinsons disease Drug Production and Capacity Analysis
4.2 Parkinsons disease Drug Revenue Analysis
4.3 Parkinsons disease Drug Price Analysis
4.4 Market Concentration Degree
5 Parkinsons disease Drug Regional Market Analysis
5.1 Parkinsons disease Drug Production by Regions
5.1.1 Global Parkinsons disease Drug Production by Regions
5.1.2 Global Parkinsons disease Drug Revenue by Regions
5.2 Parkinsons disease Drug Consumption by Regions
5.3 North America Parkinsons disease Drug Market Analysis
5.3.1 North America Parkinsons disease Drug Production
5.3.2 North America Parkinsons disease Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Parkinsons disease Drug Import and Export
5.4 Europe Parkinsons disease Drug Market Analysis
5.4.1 Europe Parkinsons disease Drug Production
5.4.2 Europe Parkinsons disease Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Parkinsons disease Drug Import and Export
5.5 China Parkinsons disease Drug Market Analysis
5.5.1 China Parkinsons disease Drug Production
5.5.2 China Parkinsons disease Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Parkinsons disease Drug Import and Export
5.6 Japan Parkinsons disease Drug Market Analysis
5.6.1 Japan Parkinsons disease Drug Production
5.6.2 Japan Parkinsons disease Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Parkinsons disease Drug Import and Export
5.7 Southeast Asia Parkinsons disease Drug Market Analysis
5.7.1 Southeast Asia Parkinsons disease Drug Production
5.7.2 Southeast Asia Parkinsons disease Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Parkinsons disease Drug Import and Export
5.8 India Parkinsons disease Drug Market Analysis
5.8.1 India Parkinsons disease Drug Production
5.8.2 India Parkinsons disease Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Parkinsons disease Drug Import and Export
6 Parkinsons disease Drug Segment Market Analysis (by Type)
6.1 Global Parkinsons disease Drug Production by Type
6.2 Global Parkinsons disease Drug Revenue by Type
6.3 Parkinsons disease Drug Price by Type
7 Parkinsons disease Drug Segment Market Analysis (by Application)
7.1 Global Parkinsons disease Drug Consumption by Application
7.2 Global Parkinsons disease Drug Consumption Market Share by Application (2014-2019)
8 Parkinsons disease Drug Major Manufacturers Analysis
8.1 Teva
8.1.1 Teva Parkinsons disease Drug Production Sites and Area Served
8.1.2 Teva Product Introduction, Application and Specification
8.1.3 Teva Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis AG
8.2.1 Novartis AG Parkinsons disease Drug Production Sites and Area Served
8.2.2 Novartis AG Product Introduction, Application and Specification
8.2.3 Novartis AG Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GSK
8.3.1 GSK Parkinsons disease Drug Production Sites and Area Served
8.3.2 GSK Product Introduction, Application and Specification
8.3.3 GSK Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 AbbVie
8.4.1 AbbVie Parkinsons disease Drug Production Sites and Area Served
8.4.2 AbbVie Product Introduction, Application and Specification
8.4.3 AbbVie Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Merck
8.5.1 Merck Parkinsons disease Drug Production Sites and Area Served
8.5.2 Merck Product Introduction, Application and Specification
8.5.3 Merck Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Boehringer Ingelheim
8.6.1 Boehringer Ingelheim Parkinsons disease Drug Production Sites and Area Served
8.6.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.6.3 Boehringer Ingelheim Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Impax Laboratories
8.7.1 Impax Laboratories Parkinsons disease Drug Production Sites and Area Served
8.7.2 Impax Laboratories Product Introduction, Application and Specification
8.7.3 Impax Laboratories Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Lundbeck
8.8.1 Lundbeck Parkinsons disease Drug Production Sites and Area Served
8.8.2 Lundbeck Product Introduction, Application and Specification
8.8.3 Lundbeck Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Sun Pharma
8.9.1 Sun Pharma Parkinsons disease Drug Production Sites and Area Served
8.9.2 Sun Pharma Product Introduction, Application and Specification
8.9.3 Sun Pharma Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Wockhardt
8.10.1 Wockhardt Parkinsons disease Drug Production Sites and Area Served
8.10.2 Wockhardt Product Introduction, Application and Specification
8.10.3 Wockhardt Parkinsons disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 UCB
8.12 Valeant Pharmaceuticals
8.13 Acadia
9 Development Trend of Analysis of Parkinsons disease Drug Market
9.1 Global Parkinsons disease Drug Market Trend Analysis
9.1.1 Global Parkinsons disease Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Parkinsons disease Drug Regional Market Trend
9.2.1 North America Parkinsons disease Drug Forecast 2019-2025
9.2.2 Europe Parkinsons disease Drug Forecast 2019-2025
9.2.3 China Parkinsons disease Drug Forecast 2019-2025
9.2.4 Japan Parkinsons disease Drug Forecast 2019-2025
9.2.5 Southeast Asia Parkinsons disease Drug Forecast 2019-2025
9.2.6 India Parkinsons disease Drug Forecast 2019-2025
9.3 Parkinsons disease Drug Market Trend (Product Type)
9.4 Parkinsons disease Drug Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Parkinsons disease Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Parkinsons disease Drug
Table Global Parkinsons disease Drug Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Parkinsons disease Drug Production Market Share by Types in 2018
Figure Carbidopa/Levodopa Product Picture
Figure Dopamine Receptor Agonists Product Picture
Figure MAO-Inhibitors Product Picture
Table Global Parkinsons disease Drug Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Parkinsons disease Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Online
Figure Retail Pharmacies
Figure Global Parkinsons disease Drug Revenue (Million USD) (2014-2025)
Figure Global Parkinsons disease Drug Production (K Doses) (2014-2025)
Figure North America Parkinsons disease Drug Market Size (Million USD) (2014-2025)
Figure Europe Parkinsons disease Drug Market Size (Million USD) (2014-2025)
Figure China Parkinsons disease Drug Market Size (Million USD) (2014-2025)
Figure Japan Parkinsons disease Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Parkinsons disease Drug Market Size (Million USD) (2014-2025)
Figure India Parkinsons disease Drug Market Size (Million USD) (2014-2025)
Table Parkinsons disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Parkinsons disease Drug in 2018
Figure Manufacturing Process Analysis of Parkinsons disease Drug
Figure Industry Chain Structure of Parkinsons disease Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Parkinsons disease Drug Manufacturing Plants Distribution
Table Parkinsons disease Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Parkinsons disease Drug Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Parkinsons disease Drug Production (K Doses) of Major Manufacturers (2014-2019)
Table Parkinsons disease Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Parkinsons disease Drug Production Share by Manufacturers in 2018
Table Parkinsons disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Parkinsons disease Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Parkinsons disease Drug Revenue Share by Manufacturers in 2018
Table Parkinsons disease Drug Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Parkinsons disease Drug Production by Regions 2014-2019 (K Doses)
Table Global Parkinsons disease Drug Production Market Share by Regions 2014-2019
Figure Global Parkinsons disease Drug Production Market Share by Regions in 2018
Table Global Parkinsons disease Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Parkinsons disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Parkinsons disease Drug Revenue Market Share by Regions in 2018
Table Global Parkinsons disease Drug Consumption by Regions 2014-2019 (K Doses)
Table Global Parkinsons disease Drug Consumption Market Share by Regions 2014-2019
Figure North America Parkinsons disease Drug Production Growth Rate 2014-2019 (K Doses)
Figure North America Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Parkinsons disease Drug Production, Consumption Import and Export (K Doses)
Figure Europe Parkinsons disease Drug Production Growth Rate 2014-2019 (K Doses)
Figure Europe Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Parkinsons disease Drug Production, Consumption Import and Export (K Doses)
Figure China Parkinsons disease Drug Production Growth Rate 2014-2019 (K Doses)
Figure China Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Parkinsons disease Drug Production, Consumption Import and Export (K Doses)
Figure Japan Parkinsons disease Drug Production Growth Rate 2014-2019 (K Doses)
Figure Japan Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Parkinsons disease Drug Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Parkinsons disease Drug Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Parkinsons disease Drug Production, Consumption Import and Export (K Doses)
Figure India Parkinsons disease Drug Production Growth Rate 2014-2019 (K Doses)
Figure India Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Parkinsons disease Drug Production, Consumption Import and Export (K Doses)
Figure Global Consumption Parkinsons disease Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Parkinsons disease Drug Market Share by Application (2014-2019)
Table Teva Parkinsons disease Drug Production Sites and Area Served
Table Teva Parkinsons disease Drug Product Introduction, Application and Specification
Table Teva Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Teva Parkinsons disease Drug Production Growth Rate (2014-2019)
Table Teva Parkinsons disease Drug Production Market Share (2014-2019)
Figure Teva Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Teva Parkinsons disease Drug Main Business and Markets Served
Table Novartis AG Parkinsons disease Drug Production Sites and Area Served
Table Novartis AG Parkinsons disease Drug Product Introduction, Application and Specification
Table Novartis AG Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Novartis AG Parkinsons disease Drug Production Growth Rate (2014-2019)
Table Novartis AG Parkinsons disease Drug Production Market Share (2014-2019)
Figure Novartis AG Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Novartis AG Parkinsons disease Drug Main Business and Markets Served
Table GSK Parkinsons disease Drug Production Sites and Area Served
Table GSK Parkinsons disease Drug Product Introduction, Application and Specification
Table GSK Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table GSK Parkinsons disease Drug Production Growth Rate (2014-2019)
Table GSK Parkinsons disease Drug Production Market Share (2014-2019)
Figure GSK Parkinsons disease Drug Revenue Market Share (2014-2019)
Table GSK Parkinsons disease Drug Main Business and Markets Served
Table AbbVie Parkinsons disease Drug Production Sites and Area Served
Table AbbVie Parkinsons disease Drug Product Introduction, Application and Specification
Table AbbVie Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table AbbVie Parkinsons disease Drug Production Growth Rate (2014-2019)
Table AbbVie Parkinsons disease Drug Production Market Share (2014-2019)
Figure AbbVie Parkinsons disease Drug Revenue Market Share (2014-2019)
Table AbbVie Parkinsons disease Drug Main Business and Markets Served
Table Merck Parkinsons disease Drug Production Sites and Area Served
Table Merck Parkinsons disease Drug Product Introduction, Application and Specification
Table Merck Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Merck Parkinsons disease Drug Production Growth Rate (2014-2019)
Table Merck Parkinsons disease Drug Production Market Share (2014-2019)
Figure Merck Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Merck Parkinsons disease Drug Main Business and Markets Served
Table Boehringer Ingelheim Parkinsons disease Drug Production Sites and Area Served
Table Boehringer Ingelheim Parkinsons disease Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Parkinsons disease Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Parkinsons disease Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Parkinsons disease Drug Main Business and Markets Served
Table Impax Laboratories Parkinsons disease Drug Production Sites and Area Served
Table Impax Laboratories Parkinsons disease Drug Product Introduction, Application and Specification
Table Impax Laboratories Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Impax Laboratories Parkinsons disease Drug Production Growth Rate (2014-2019)
Table Impax Laboratories Parkinsons disease Drug Production Market Share (2014-2019)
Figure Impax Laboratories Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Impax Laboratories Parkinsons disease Drug Main Business and Markets Served
Table Lundbeck Parkinsons disease Drug Production Sites and Area Served
Table Lundbeck Parkinsons disease Drug Product Introduction, Application and Specification
Table Lundbeck Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Lundbeck Parkinsons disease Drug Production Growth Rate (2014-2019)
Table Lundbeck Parkinsons disease Drug Production Market Share (2014-2019)
Figure Lundbeck Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Lundbeck Parkinsons disease Drug Main Business and Markets Served
Table Sun Pharma Parkinsons disease Drug Production Sites and Area Served
Table Sun Pharma Parkinsons disease Drug Product Introduction, Application and Specification
Table Sun Pharma Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Sun Pharma Parkinsons disease Drug Production Growth Rate (2014-2019)
Table Sun Pharma Parkinsons disease Drug Production Market Share (2014-2019)
Figure Sun Pharma Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Sun Pharma Parkinsons disease Drug Main Business and Markets Served
Table Wockhardt Parkinsons disease Drug Production Sites and Area Served
Table Wockhardt Parkinsons disease Drug Product Introduction, Application and Specification
Table Wockhardt Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Wockhardt Parkinsons disease Drug Production Growth Rate (2014-2019)
Table Wockhardt Parkinsons disease Drug Production Market Share (2014-2019)
Figure Wockhardt Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Wockhardt Parkinsons disease Drug Main Business and Markets Served
Table UCB Parkinsons disease Drug Production Sites and Area Served
Table Valeant Pharmaceuticals Parkinsons disease Drug Production Sites and Area Served
Table Acadia Parkinsons disease Drug Production Sites and Area Served
Figure Global Parkinsons disease Drug Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Parkinsons disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Parkinsons disease Drug Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Parkinsons disease Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Parkinsons disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Parkinsons disease Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Parkinsons disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Parkinsons disease Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Parkinsons disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Parkinsons disease Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Parkinsons disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Parkinsons disease Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Parkinsons disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Parkinsons disease Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Parkinsons disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Parkinsons disease Drug by Type (2019-2025)
Table Global Consumption (K Doses) of Parkinsons disease Drug by Application (2019-2025)
Table Parkinsons disease Drug Distributors List
Table Parkinsons disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs